Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

by Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B
Published 2013-07-01

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

by Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T
Published 2012-08-01

Treatment Costs for Patients with Chronic Kidney Disease Who Received Multidisciplinary Care in a District Hospital in Thailand

by Songsermlosakul S, Permsuwan U, Singhan W
Published 2020-04-01

Disparities in Emergency Transport of Women with a Preterm Labor Diagnosis in Urban vs Rural Areas in the US

by Vilalta A, Troeger KA
Published 2020-06-01

Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil

by Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L
Published 2016-10-01

Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

by Pöhlmann J, Montagnoli R, Lastoria G, Parekh W, Markert M, Hunt B
Published 2019-10-01

Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US settin...

by Hernández-Madrid A, Lu X, Tsintzos SI, Fagan DH, Klepfer RN, Matía R, Chung ES
Published 2019-06-01

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe

by Verleger K, Penrod JR, Manley Daumont M, Solem C, Luo L, Macahilig C, Hertel N
Published 2020-01-01

Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequenc...

by Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, Kim YT, Kim YM, Kang S
Published 2013-07-01

Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder

by Yan T, Greene M, Chang E, Houle CR, Tarbox MH, Broder MS
Published 2020-02-01

Standard Gamble to Derive Utility Health States for Limbal Stem Cell Deficiency

by Smith AB, Retzler J, Taylor MJ
Published 2020-09-01

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective

by Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P
Published 2018-07-01

A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk

by Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R
Published 2018-10-01

Cost of Hypertension Illness and Associated Factors Among Patients Attending Hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia

by Zawudie AB, Lemma TD, Daka DW
Published 2020-04-01

Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, Ethiopia

by Kassa DA, Mekonnen S, Kebede A, Haile TG
Published 2020-07-01

US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma

by Bassali J, Gould IG, Kaye JA, Mladsi D, Mehta J
Published 2020-06-01

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

by Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL
Published 2020-04-01

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

by Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M
Published 2019-11-01

Health-care utilization and outcomes of patients at high risk of invasive fungal infection

by Fu R, Gundrum J, Sung AH
Published 2018-07-01

Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective

by Macaulay R, Ahuja A, Ademisoye E, Juarez-Garcia A, Shaw JW
Published 2019-03-01